FI980341A0 - 2-oxy-indole derivatives - Google Patents

2-oxy-indole derivatives

Info

Publication number
FI980341A0
FI980341A0 FI980341A FI980341A FI980341A0 FI 980341 A0 FI980341 A0 FI 980341A0 FI 980341 A FI980341 A FI 980341A FI 980341 A FI980341 A FI 980341A FI 980341 A0 FI980341 A0 FI 980341A0
Authority
FI
Finland
Prior art keywords
oxy
indole derivatives
derivatives
vasopressin
sulphonyl
Prior art date
Application number
FI980341A
Other languages
Finnish (fi)
Swedish (sv)
Other versions
FI980341A7 (en
FI980341L (en
Inventor
Loic Foulon
Georges Garcia
Dino Nisato
Richard Roux
Claudine Serradeil-Legal
Gerard Valette
Jean Wagnon
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Priority to FI980341A priority Critical patent/FI980341L/en
Publication of FI980341A0 publication Critical patent/FI980341A0/en
Publication of FI980341A7 publication Critical patent/FI980341A7/en
Publication of FI980341L publication Critical patent/FI980341L/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/80—[b, c]- or [b, d]-condensed
    • C07D209/90—Benzo [c, d] indoles; Hydrogenated benzo [c, d] indoles
    • C07D209/92—Naphthostyrils
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32—Oxygen atoms
    • C07D209/34—Oxygen atoms in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/96—Spiro-condensed ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10—Spiro-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/10—Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

N-sulphonyl-2-oxoindole derivatives of formula (I), and any salts thereof, preparation thereof and pharmaceutical compositions containing said derivatives. These compounds have an affinity for vasopressin and/or ocytocin receptors.
FI980341A 1992-01-30 1993-01-28 2-Oxyindole derivatives FI980341L (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FI980341A FI980341L (en) 1992-01-30 1993-01-28 2-Oxyindole derivatives

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
FR9201034A FR2686878B1 (en) 1992-01-30 1992-01-30 DERIVATIVES OF N-SULFONYL OXO-2 INDOLE, THEIR PREPARATION, THE PHARMACEUTICAL COMPOSITIONS CONTAINING SAME.
FI934274A FI934274A7 (en) 1992-01-30 1993-01-28 N-sulfonyl-2-oxyindole derivatives, their preparation and pharmaceutical compositions containing them
FI980341A FI980341L (en) 1992-01-30 1993-01-28 2-Oxyindole derivatives
PCT/FR1993/000093 WO1993015051A1 (en) 1992-01-30 1993-01-28 N-sulphonyl-2-oxoindole derivatives having affinity for vasopressin and/or ocytocin receptors

Publications (3)

Publication Number Publication Date
FI980341A0 true FI980341A0 (en) 1998-02-13
FI980341A7 FI980341A7 (en) 1998-02-13
FI980341L FI980341L (en) 1998-02-13

Family

ID=9426168

Family Applications (2)

Application Number Title Priority Date Filing Date
FI934274A FI934274A7 (en) 1992-01-30 1993-01-28 N-sulfonyl-2-oxyindole derivatives, their preparation and pharmaceutical compositions containing them
FI980341A FI980341L (en) 1992-01-30 1993-01-28 2-Oxyindole derivatives

Family Applications Before (1)

Application Number Title Priority Date Filing Date
FI934274A FI934274A7 (en) 1992-01-30 1993-01-28 N-sulfonyl-2-oxyindole derivatives, their preparation and pharmaceutical compositions containing them

Country Status (20)

Country Link
EP (1) EP0581939B1 (en)
JP (1) JPH06507182A (en)
AT (1) ATE180773T1 (en)
AU (1) AU662960B2 (en)
BR (1) BR9303993A (en)
CA (1) CA2107348A1 (en)
CZ (1) CZ203793A3 (en)
DE (1) DE69325130D1 (en)
FI (2) FI934274A7 (en)
FR (1) FR2686878B1 (en)
HU (1) HUT68642A (en)
IL (1) IL104559A0 (en)
MX (1) MX9300498A (en)
NO (1) NO180538C (en)
NZ (1) NZ249158A (en)
RU (1) RU2135469C1 (en)
SK (1) SK105393A3 (en)
TW (1) TW239126B (en)
WO (1) WO1993015051A1 (en)
ZA (1) ZA93649B (en)

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5849780A (en) * 1992-01-30 1998-12-15 Sanofi 1-benzenesulfonyl-1-1,3-dihydroindol-2-one derivatives, their preparation and pharmaceutical compositions in which they are present
FR2708605A1 (en) * 1993-07-30 1995-02-10 Sanofi Sa N-sulfonylindol-2-one derivatives, their preparation, pharmaceutical compositions containing them.
US5686624A (en) * 1992-01-30 1997-11-11 Sanofi 1-benzenesulfonyl-1,3-dihydro-indol-2-one derivatives, their preparation and pharmaceutical compositions in which they are present
FR2708608B1 (en) * 1993-07-30 1995-10-27 Sanofi Sa N-sulfonylbenzimidazolone derivatives, their preparation, pharmaceutical compositions containing them.
FR2708606B1 (en) * 1993-07-30 1995-10-27 Sanofi Sa N-phenylalkylindol-2-one derivatives, their preparation, pharmaceutical compositions containing them.
FR2714378B1 (en) * 1993-12-24 1996-03-15 Sanofi Sa Indol-2-one derivatives substituted in 3 with a nitrogen group, their preparation, pharmaceutical compositions containing them.
FR2722190B1 (en) * 1994-07-05 1996-10-04 Sanofi Sa 1-BENZYL-1,3-DIHYDRO-2H-BENZIMIDAZOL-2-ONE DERIVATIVES, THEIR PREPARATION, THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
AU5772196A (en) * 1995-05-19 1996-11-29 Chiroscience Limited 3,4-disubstituted-phenylsulphonamides and their therapeutic use
FR2740136B1 (en) * 1995-10-24 1998-01-09 Sanofi Sa INDOLIN-2-ONE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
US5756497A (en) * 1996-03-01 1998-05-26 Merck & Co., Inc. Tocolytic oxytocin receptor antagonists
MXPA02000670A (en) 1999-07-21 2002-07-02 Astrazeneca Ab New compounds.
GB9918684D0 (en) * 1999-08-09 1999-10-13 Novartis Ag Organic compounds
US7186745B2 (en) 2001-03-06 2007-03-06 Astrazeneca Ab Indolone derivatives having vascular damaging activity
SE0200979D0 (en) * 2002-03-28 2002-03-28 Astrazeneca Ab New compounds
DE10222034A1 (en) * 2002-05-17 2003-11-27 Bayer Ag New 2-benzenesulfonyl-3,4-dihydro-2(1H)-isoquinoline derivatives, are PPAR-delta activators useful e.g. for treating coronary heart disease, dyslipidemia or restenosis
BR0312176A (en) * 2002-06-21 2005-04-05 Suven Life Sciences Ltd Compound, pharmaceutical composition, use of a compound, method of treatment, method of reducing morbidity and mortality associated with overweight, process for preparing a compound, new intermediate and process for preparing a new intermediate
RU2259999C2 (en) * 2003-08-26 2005-09-10 ООО "Исследовательский институт химического разнообразия" 1-sulfonyl-1,3-dihydroindole-2-ones, pharmaceutical compositions (variants), method for their preparing and applying
US8580842B2 (en) 2003-09-30 2013-11-12 Abbott Gmbh & Co. Kg Heteroaryl-substituted 1,3-dihydroindol-2-one derivatives and medicaments containing them
US20050070718A1 (en) 2003-09-30 2005-03-31 Abbott Gmbh & Co. Kg Heteroaryl-substituted 1,3-dihydroindol-2-one derivatives and medicaments containing them
US7517899B2 (en) 2004-03-30 2009-04-14 Wyeth Phenylaminopropanol derivatives and methods of their use
US7414052B2 (en) 2004-03-30 2008-08-19 Wyeth Phenylaminopropanol derivatives and methods of their use
US20120115842A1 (en) * 2004-12-31 2012-05-10 Wilfried Lubisch Substituted Oxindole Derivatives, Medicaments Containing Said Derivatives and Use Thereof
WO2006080574A1 (en) * 2005-01-28 2006-08-03 Taisho Pharmaceutical Co., Ltd. 1,3-dihydro-2h-indole-2-one compound and pyrrolidine-2-one compound fused with aromatic heterocycle
DE102005014904A1 (en) * 2005-03-26 2007-02-01 Abbott Gmbh & Co. Kg New substituted oxindole derivatives are vasopressin receptor binders useful to treat e.g. diabetes insipidus, enuresis nocturna, incontinence, hypertonia, heart failure, myocardial infarction, coronary spasm and renal disorders
JP2008534461A (en) 2005-03-24 2008-08-28 アボット ゲーエムベーハー ウント カンパニー カーゲー Substituted oxindole derivatives, medicaments containing said derivatives and uses thereof
DE102005014936A1 (en) 2005-03-24 2006-12-14 Abbott Gmbh & Co. Kg New substituted oxindole derivatives are vasopressin receptor binders useful to treat e.g. diabetes insipidus, enuresis nocturna, incontinence, hypertonia, heart failure, myocardial infarction, coronary spasm and renal disorders
DE102005015957A1 (en) * 2005-03-31 2006-10-05 Abbott Gmbh & Co. Kg New substituted oxindole derivatives are vasopressin receptor binders useful to treat e.g. diabetes insipidus, enuresis nocturna, incontinence, hypertonia, heart failure, myocardial infarction, coronary spasm and renal disorders
AR053710A1 (en) 2005-04-11 2007-05-16 Xenon Pharmaceuticals Inc SPIROHETEROCICLIC COMPOUNDS AND THEIR USES AS THERAPEUTIC AGENTS
MY158766A (en) 2005-04-11 2016-11-15 Xenon Pharmaceuticals Inc Spiro-oxindole compounds and their uses as therapeutic agents
JP2009507800A (en) 2005-09-09 2009-02-26 ユーロ−セルティーク エス．エイ． Fused and spirocyclic compounds and uses thereof
JP2009517444A (en) 2005-12-02 2009-04-30 アボット ゲーエムベーハー ウント カンパニー カーゲー Substituted oxindole derivatives, medicaments containing the same and uses thereof
DE102006040915A1 (en) 2006-08-26 2008-03-20 Abbott Gmbh & Co. Kg New oxindole derivatives useful for treating vasopressin- or oxytocin-dependent diseases
TWI403508B (en) 2006-08-26 2013-08-01 Abbott Gmbh & Co Kg Substituted benzimidazolone derivatives, medicaments comprising them and their use
EP2076517A1 (en) * 2006-09-22 2009-07-08 Janssen Pharmaceutica N.V. Spiro benzazepines as vasopressin antagonists
SI2078022T1 (en) * 2006-09-22 2012-01-31 Janssen Pharmaceutica Nv Spiro benzazepines used as vasopressin antagonists
CA2665698A1 (en) 2006-10-12 2008-05-22 Xenon Pharmaceuticals Inc. Use of spiro-oxindole compounds as therapeutic agents
FR2909668B1 (en) * 2006-12-12 2009-01-23 Sanofi Aventis Sa 5-ALKYLOXY-INDOLIN-2-ONE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATIONS
US20080167286A1 (en) 2006-12-12 2008-07-10 Abbott Laboratories Pharmaceutical compositions and their methods of use
US8486979B2 (en) 2006-12-12 2013-07-16 Abbvie Inc. 1,2,4 oxadiazole compounds and methods of use thereof
UY30846A1 (en) 2006-12-30 2008-07-31 Abbott Gmbh & Amp OXINDOL DERIVATIVES REPLACED, MEDICINES THAT UNDERSTAND AND USE THEMSELVES
WO2009071687A1 (en) 2007-12-07 2009-06-11 Abbott Gmbh & Co. Kg Amidomethyl-substituted oxindole derivatives and the use thereof for the treatment of vasopressin-dependent illnesses
US8703774B2 (en) 2007-12-07 2014-04-22 AbbVie Deutschland GmbH & Co. KG Carbamate-substituted oxindole derivatives and use thereof for the treatment of vasopressin-dependent diseases
EP2623504A1 (en) 2007-12-07 2013-08-07 Abbott GmbH & Co. KG 5,6-Disubstituted oxindole derivatives and their use in the manufacture of a medicament for the treatment of vasopressin-dependent diseases
CA2707669C (en) 2007-12-07 2016-07-05 Wilfried Braje 5-halogen-substituted oxindole derivatives and use thereof for treating vasopressine-dependent diseases
CA2710946C (en) 2007-12-27 2016-05-31 Abbott Gmbh & Co. Kg Substituted oxindole-derivatives and the use thereof for the treatment of vasopressin-dependent illnesses
FR2927625B1 (en) 2008-02-19 2010-03-12 Sanofi Aventis NOVEL 3-AMINOALKYL-1,3-DIHYDRO-2H-INDOL-2-ONE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC USE
FR2930249B1 (en) * 2008-04-21 2010-05-14 Sanofi Aventis NOVEL 3-AMINOALKYL-1,3-DIHYDRO-2H-INDOL-2-ONE DERIVATIVES, THEIR PREPARATION AND THERAPEUTIC USE THEREOF
EP2350091B1 (en) 2008-10-17 2015-06-03 Xenon Pharmaceuticals Inc. Spiro-oxindole compounds and their use as therapeutic agents
SG10201703086VA (en) 2008-10-17 2017-05-30 Xenon Pharmaceuticals Inc Spiro-oxindole compounds and their use as therapeutic agents
WO2010138600A2 (en) 2009-05-29 2010-12-02 Abbott Laboratories Pharmaceutical compositions for the treatment of pain
AR077252A1 (en) 2009-06-29 2011-08-10 Xenon Pharmaceuticals Inc ESPIROOXINDOL COMPOUND ENANTIOMERS AND THEIR USES AS THERAPEUTIC AGENTS
JP5752136B2 (en) 2009-10-14 2015-07-22 ゼノン・ファーマシューティカルズ・インコーポレイテッドＸｅｎｏｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｉｎｃ． Synthetic methods for spiro-oxindole compounds
CN105726531A (en) 2010-02-26 2016-07-06 泽农医药公司 Pharmaceutical compositions of spiro-oxindole compound for topical administration and their use as therapeutic agents
EP2881391A1 (en) 2013-12-05 2015-06-10 Bayer Pharma Aktiengesellschaft Spiroindoline carbocycle derivatives and pharmaceutical compositions thereof
TW201636017A (en) 2015-02-05 2016-10-16 梯瓦製藥國際有限責任公司 Methods of treating postherpetic neuralgia with a topical formulation of a spiro-oxindole compound
AU2017209023B2 (en) * 2016-01-20 2021-06-17 Chemocentryx, Inc. 2-oxindole compounds
CN114702448A (en) * 2021-09-30 2022-07-05 西南大学 Synthetic method of trifluoromethylated tandem cyclized spiro compounds of cycloalkenes
CN119019312B (en) * 2024-10-24 2025-01-28 苏州宜联生物医药有限公司 Indol-2-one derivative, antibody drug conjugate thereof and application thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2540057A (en) 1947-07-02 1951-01-30 Gen Aniline & Film Corp Aromatic and heterocyclic diazosulfones
US3838167A (en) * 1972-08-01 1974-09-24 Lilly Co Eli Process for preparing indoles
DK167393B1 (en) 1985-12-30 1993-10-25 Roussel Uclaf 1-SULPHONYL-2-OXO-PYRROLIDINE DERIVATIVES, THEIR PREPARATION AND PHARMACEUTICAL PREPARATIONS CONTAINING THEREOF
US4863437A (en) * 1986-03-20 1989-09-05 Clarke Ellis W Means for fluid administration
US4803217A (en) * 1986-12-24 1989-02-07 Merck & Co., Inc. Hapalindolinone compounds as vassopressin antagonists
EP0303418A3 (en) * 1987-08-11 1990-11-07 Smithkline Beecham Laboratoires Pharmaceutiques Substituted indolones, useful in the treatment of heart or asthmatic diseases
KR930011300B1 (en) * 1989-07-25 1993-11-29 다이호오 야꾸힌 고오교오 가부시끼가이샤 Oxindole derivative

Also Published As

Publication number Publication date
NZ249158A (en) 1996-02-27
HU9302762D0 (en) 1993-12-28
AU3504393A (en) 1993-09-01
EP0581939A1 (en) 1994-02-09
NO933482D0 (en) 1993-09-29
AU662960B2 (en) 1995-09-21
NO180538C (en) 1997-05-07
NO933482L (en) 1993-11-29
BR9303993A (en) 1994-08-02
FI934274A0 (en) 1993-09-29
TW239126B (en) 1995-01-21
MX9300498A (en) 1994-07-29
ATE180773T1 (en) 1999-06-15
FR2686878A1 (en) 1993-08-06
DE69325130D1 (en) 1999-07-08
FI934274L (en) 1993-09-29
CA2107348A1 (en) 1993-07-31
FR2686878B1 (en) 1995-06-30
SK105393A3 (en) 1994-08-10
RU2135469C1 (en) 1999-08-27
IL104559A0 (en) 1993-05-13
ZA93649B (en) 1993-09-02
EP0581939B1 (en) 1999-06-02
FI980341A7 (en) 1998-02-13
FI934274A7 (en) 1993-09-29
HUT68642A (en) 1995-07-28
NO180538B (en) 1997-01-27
JPH06507182A (en) 1994-08-11
FI980341L (en) 1998-02-13
WO1993015051A1 (en) 1993-08-05
CZ203793A3 (en) 1994-04-13

Similar Documents

Publication Publication Date Title
FI980341A0 (en) 2-oxy-indole derivatives
ES2044836T3 (en) DERIVED FROM PIPERIDINE, ITS USE AND PHARMACEUTICAL COMPOUND CONTAINING IT.
NO921835D0 (en) PROCEDURE FOR THE PREPARATION OF AMIDINOPHENYLALANINE DERIVATIVES AND USE THEREOF
SE8300736D0 (en) NOVEL PHARMACOLOGICALLY ACTIVE COMPOUNDS
UY24555A1 (en) NEW COMPOUNDS
IL124537A0 (en) Naphthyl-substituted benzimidazole derivatives and pharmaceutical compositions containing the same
AU6542986A (en) Pyridyl-methylthio substituted benzimidazoles
DE60100506D1 (en) 1,3-DIHYDRO-2H-INDOL-2-ON DERIVATIVES AND THEIR USE AS LIGANDS OF ARGININE VASOPRESSIN RECEPTORS V1B OR V1B AND V1A
ES2174298T3 (en) DERIVATIVES OF AMINOTIAZOL, ITS PREPARATION PROCEDURE AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
MX9203417A (en) ANTIATEROESCLEROTIC DIARILO COMPOUNDS.
TR199801268T2 (en) 3-Azetidinylalkylpiperidines or pyrrolidines as tachykinin antagonists.
KR960703863A (en) New Bis-naphthalimides for the Treatment of Cancer
DE69330601D1 (en) SEROTON INERGIC ERGOLIN DERIVATIVES
ATE200291T1 (en) CEPHEM DERIVATIVES
ES2132245T3 (en) DERIVATIVES OF 1-AZAADAMANTHANE AS 5-HT AGONISTS OR ANTAGONISTS.
NO950177L (en) Pharmacologically active derivatives
ATE285771T1 (en) ANTI-CANCER COMPOSITION CONTAINING DIAMINOTRIFLUOROMETHYLPYRIMIDENE DERIVATIVES
TW371661B (en) Novel intermediates and their use to prepare N,N'-bridged bisindolylmaleimides
NO994135D0 (en) quinoxalinediones
SE9203824D0 (en) BENZOFURANY LIMIDAZOLE DERIVATIVES AND PROCESS FOR THE PREPARATION AND THERAPEUTICAL COMPOSITIONS CONTAINING THE SAME
ES2162986T3 (en) DERIVATIVES OF MERCAPTO-ALCANOIL-DIPEPTIDES, ITS PREPARATION PROCEDURE AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
ATE217619T1 (en) ENDOTHELIN RECEPTOR ANTAGONISTS
DE69528984D1 (en) INHIBITION OF LEUKOTRIA BIOSYNTHESIS BY URINE DERIVATIVES